These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33632967)

  • 1. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply.
    Kasi SG; Shah A
    Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 Vaccine in Children: Where Do We Stand?
    Kumar J; Meena J
    Indian Pediatr; 2021 Feb; 58(2):194-195. PubMed ID: 33632966
    [No Abstract]   [Full Text] [Related]  

  • 3. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 4. ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2021 Jun; 397(10291):2248. PubMed ID: 34119059
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Logunov DY; Dolzhikova IV; Tukhvatullin AI; Shcheblyakov DV
    Lancet; 2020 Oct; 396(10256):e54-e55. PubMed ID: 32971043
    [No Abstract]   [Full Text] [Related]  

  • 6. The Covid-19 Vaccine-Development Multiverse. Reply.
    Heaton PM
    N Engl J Med; 2021 Feb; 384(7):682. PubMed ID: 33503339
    [No Abstract]   [Full Text] [Related]  

  • 7. Mandatory Coronavirus Disease 2019 Vaccine for Children?-Reply.
    Opel DJ; Diekema DS; Ross LF
    JAMA Pediatr; 2021 May; 175(5):534. PubMed ID: 33555288
    [No Abstract]   [Full Text] [Related]  

  • 8. Authors' Reply to Sprengholz and Betsch: "Willingness to Pay for a COVID-19 Vaccine".
    García LY; Cerda AA
    Appl Health Econ Health Policy; 2021 Jul; 19(4):623-624. PubMed ID: 33973149
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection.
    Harder T; Koch J; Vygen-Bonnet S; Külper-Schiek W; Pilic A; Reda S; Scholz S; Wichmann O
    Euro Surveill; 2021 Sep; 26(35):. PubMed ID: 34477051
    [No Abstract]   [Full Text] [Related]  

  • 10. Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Logunov DY; Dolzhikova IV; Shcheblyakov DV
    Lancet; 2021 May; 397(10288):1883-1884. PubMed ID: 33991474
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

  • 12. The promise of COVID-19 vaccines. Authors' reply.
    Sokolska JM; Kurcz J; Kosmala W
    Kardiol Pol; 2022; 80(1):111-112. PubMed ID: 34981827
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reply to "Defining priorities, the case of of COVID-19 vaccine"].
    Indolfi C; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Romeo F; Sinagra G; Filardi PP
    G Ital Cardiol (Rome); 2021 Jun; 22(6):510-511. PubMed ID: 34037598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Do we need a pediatric COVID-19 vaccine?].
    Eberhardt CS; Siegrist CA
    Rev Med Suisse; 2021 Feb; 17(726):353-357. PubMed ID: 33599412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine development: What lessons can we learn from TB?
    Safar HA; Mustafa AS; McHugh TD
    Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):56. PubMed ID: 33256750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Jun; 397(10291):2249-2250. PubMed ID: 34119061
    [No Abstract]   [Full Text] [Related]  

  • 18. The Covid-19 Vaccine-Development Multiverse.
    Kojima N; Turner I; Klausner JD
    N Engl J Med; 2021 Feb; 384(7):681-682. PubMed ID: 33503338
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.
    Goren A; Cadegiani FA; Wambier CG; Vano-Galvan S; Tosti A; Shapiro J; Mesinkovska NA; Ramos PM; Sinclair R; Lupi O; Hercogova J; McCoy J
    Med Hypotheses; 2021 Jan; 146():110439. PubMed ID: 33308937
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control.
    Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A
    Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.